GO:0015226 carnitine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015226 (carnitine transmembrane transporter activity) is a molecular function that enables the transfer of carnitine across a membrane, a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane.
• The term is synonymous with vitamin Bt transporter activity and is mediated by membrane proteins such as SLC22A5 (OCTN2), SLC6A14, and other carnitine carriers.
• Carnitine transport is essential for fatty acid oxidation, as carnitine shuttles acyl groups into mitochondria for beta-oxidation.
• Dysfunction of carnitine transporters is linked to primary carnitine deficiency, metabolic disorders, and cancer progression, including pancreatic cancer recurrence.
• Key experimental approaches to study this activity include transport assays, knockout and point-mutation cell models, and CRISPR screening.
• Understanding GO:0015226 supports research in metabolism, mitochondrial biology, and therapeutic targeting of carnitine-dependent pathways.
Description
Carnitine transmembrane transporter activity (GO:0015226) is a molecular function that enables the movement of carnitine across biological membranes. Carnitine is a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane, a critical step in fatty acid oxidation and energy metabolism. This activity is mediated by specific membrane proteins that recognize and translocate carnitine, thereby regulating cellular carnitine homeostasis. Researchers study this term to understand how cells import carnitine for mitochondrial function and how defects in transport contribute to disease. The importance of carnitine transport extends beyond basic metabolism; recent evidence links carnitine uptake to cancer-associated fibroblast signaling and tumor recurrence, highlighting its broader pathophysiological relevance. As a molecular function, GO:0015226 is a focal point for investigating membrane transport mechanisms, substrate specificity, and the role of carnitine in health and disease.
carnitine transmembrane transporter activity At A Glance
| GO ID | GO:0015226 |
|---|---|
| GO term | carnitine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | vitamin Bt transporter activity |
| Major function | Enables the transfer of carnitine across a membrane, supporting acyl group transfer across the inner mitochondrial membrane. |
| Representative genes | SLC22A5 (OCTN2), SLC6A14, SLC22A4 |
| Associated diseases | Primary carnitine deficiency, metabolic disorders, pancreatic cancer |
| Research methods | Transport assays, CRISPR knockout, point mutations, overexpression |
What Is GO:0015226?
In simple terms, GO:0015226 describes the ability of a protein to carry carnitine across a cell membrane. According to the Gene Ontology, this activity enables the transfer of carnitine across a membrane, where carnitine is a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane. This function is synonymous with vitamin Bt transporter activity and is typically associated with integral membrane proteins that facilitate carnitine uptake or efflux.
Why Is carnitine transmembrane transporter activity Important in Cell Biology?
Carnitine transmembrane transporter activity is essential for cellular energy metabolism because carnitine is required for the transport of long-chain fatty acids into mitochondria for beta-oxidation. Defects in this activity can lead to primary carnitine deficiency, a disorder characterized by reduced carnitine uptake and impaired fatty acid oxidation. Beyond metabolic disease, carnitine transport has been implicated in cancer biology, where cancer-associated fibroblasts can supply carnitine to tumor cells via SLC6A14, promoting pancreatic cancer recurrence. Thus, understanding GO:0015226 provides insights into fundamental membrane transport mechanisms and offers potential therapeutic targets for metabolic and oncological diseases.
• Carnitine transport is required for mitochondrial fatty acid oxidation and energy production.
• Mutations in the carnitine transporter SLC22A5 cause primary carnitine deficiency.
• SLC6A14-mediated carnitine uptake from cancer-associated fibroblasts promotes pancreatic cancer recurrence.
• Carnitine transporters are subject to glycosylation, which affects their function and trafficking.
• Substrate discrimination between carnitine and other compounds is determined by specific amino acids in the transporter.
• Carnitine transport is relevant to retroviral biology and lipid metabolism.
• The activity is a potential drug target for modulating fatty acid oxidation in metabolic disorders.
• Studying this term aids in understanding endoplasmic reticulum transport processes.
Molecular Mechanism of carnitine transmembrane transporter activity
Substrate Recognition and Binding
In simple terms: The transporter protein recognizes carnitine and binds it specifically.
Carnitine transporters such as SLC22A5 (OCTN2) and SLC6A14 selectively bind carnitine through specific amino acid residues. Studies on SLC22A5 and SLC22A4 have shown that interchange of selected amino acids can switch substrate specificity, indicating that precise molecular interactions govern carnitine recognition. Glycosylation of OCTN2 also influences its transport activity and stability.
Translocation Across the Membrane
In simple terms: After binding, the transporter moves carnitine across the cell membrane.
The transporter undergoes conformational changes to shuttle carnitine from one side of the membrane to the other. This process is energy-dependent or driven by ion gradients, depending on the transporter family. Mitochondrial carrier proteins, for example, facilitate the transfer of carnitine and acylcarnitines across the inner mitochondrial membrane.
Role in Acyl Group Transfer
In simple terms: Carnitine carries fatty acid groups into mitochondria for energy production.
Once inside the mitochondrial matrix, carnitine participates in the transfer of acyl groups across the inner mitochondrial membrane, a key step in fatty acid beta-oxidation. This function is essential for energy homeostasis, and its disruption leads to metabolic imbalances.
Regulation by Cellular Signals
In simple terms: The activity of carnitine transporters can be turned up or down by cellular signals.
Carnitine transport activity is regulated by factors such as PPARγ signaling in cancer-associated fibroblasts, which influences SLC6A14 expression and carnitine uptake. Additionally, p53 regulates oxidative stress in skeletal muscle, potentially affecting carnitine metabolism. Transport and transporters in the endoplasmic reticulum also contribute to cellular carnitine distribution.
Key Genes Involved in GO:0015226 carnitine transmembrane transporter activity
The following genes encode proteins that mediate or regulate carnitine transmembrane transporter activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC22A5 | High-affinity carnitine transporter (OCTN2) | Mutations cause primary carnitine deficiency; glycosylation affects function |
| SLC6A14 | Carnitine uptake transporter in cancer-associated fibroblasts | Promotes pancreatic cancer recurrence via PPARγ signaling |
| SLC22A4 | Related organic cation transporter | Substrate discrimination studies with SLC22A5 |
| SLC25A20 | Mitochondrial carnitine-acylcarnitine carrier | Involved in acyl group transfer across inner mitochondrial membrane |
| CPT1A | Carnitine palmitoyltransferase 1 | Links carnitine transport to fatty acid oxidation |
| CPT2 | Carnitine palmitoyltransferase 2 | Mitochondrial enzyme in carnitine shuttle |
| PPARγ | Regulates SLC6A14 expression | Cancer-associated fibroblast signaling |
| p53 | Regulates oxidative stress in skeletal muscle | Potential link to carnitine metabolism |
| SLC25A29 | Mitochondrial carnitine transporter | Involved in mitochondrial transport |
| SLC25A45 | Mitochondrial carrier protein | Potential carnitine transport |
| OCTN1 | Organic cation/carnitine transporter | Substrate specificity studies |
| OCTN2 | Carnitine transporter | Primary carnitine deficiency |
| SLC22A16 | Carnitine transporter | Potential role in metabolism |
| CT1 | Carnitine transporter | Transport assays |
| ATB0,+ | Amino acid transporter with carnitine transport activity | SLC6A14 alias |
| SLC7A5 | Amino acid transporter | Indirect carnitine transport |
| SLC3A2 | Chaperone for SLC7A5 | Indirect carnitine transport |
| SLC25A1 | Mitochondrial citrate carrier | Related mitochondrial transport |
How Is carnitine transmembrane transporter activity Regulated?
Carnitine transmembrane transporter activity is regulated at multiple levels. Transcriptional regulation of SLC6A14 by PPARγ in cancer-associated fibroblasts enhances carnitine uptake, promoting pancreatic cancer recurrence. Post-translational modifications such as glycosylation of OCTN2 affect its transport activity and stability. Additionally, p53 regulates oxidative stress in skeletal muscle, which may influence carnitine metabolism. Transport and transporters in the endoplasmic reticulum also contribute to cellular carnitine distribution.
carnitine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC22A5 | Primary carnitine deficiency | Knockout cell model, point mutation knock-in |
| SLC6A14 | Pancreatic cancer recurrence | Overexpression in cancer-associated fibroblasts |
| SLC22A4 | Substrate discrimination defects | Point mutation knock-in |
| PPARγ | Cancer-associated fibroblast signaling | Knockout or overexpression |
| p53 | Oxidative stress in skeletal muscle | Knockout and point mutation |
Primary Carnitine Deficiency
Primary carnitine deficiency is an inherited disorder caused by mutations in SLC22A5 (OCTN2), leading to impaired carnitine transport and reduced fatty acid oxidation. Glycosylation defects in OCTN2 can further compromise its function, resulting in metabolic crises and cardiomyopathy.
Pancreatic Cancer Recurrence
SLC6A14-mediated carnitine uptake from PPARγ-positive cancer-associated fibroblasts promotes pancreatic cancer recurrence, highlighting a role for carnitine transport in tumor microenvironment interactions.
Metabolic and Oxidative Stress Disorders
Altered carnitine transport affects oxidative stress regulation in skeletal muscle, where p53 modulates antioxidant responses. This links carnitine transporter activity to broader metabolic and oxidative stress-related pathologies.
Retroviral Infections
Lipids and carnitine metabolism may influence retroviral replication, as suggested by studies on lipid requirements for retroviruses.
From carnitine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC22A5 affect carnitine uptake? | CRISPR knockout cell line |
| Does a specific point mutation in SLC22A5 alter substrate specificity? | Point mutation knock-in |
| Can overexpression of SLC6A14 enhance carnitine transport? | Overexpression cell model |
| Does glycosylation of OCTN2 affect its function? | Point mutation knock-in at glycosylation sites |
| Does PPARγ regulate SLC6A14 expression? | Knockout and overexpression |
| Does p53 modulate carnitine metabolism? | Knockout and point mutation |
How to Study the carnitine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled carnitine uptake | Transport activity | Functional characterization of transporters |
| CRISPR knockout | Loss-of-function effects | Gene function studies |
| Point mutation knock-in | Effect of specific mutations | Substrate specificity and glycosylation |
| Overexpression | Gain-of-function effects | Cancer and metabolic studies |
| RNA-seq | Gene expression changes | Regulation by PPARγ |
| Western blot | Protein expression and glycosylation | OCTN2 studies |
| Mass spectrometry | Glycosylation profiling | Post-translational modifications |
| Immunofluorescence | Subcellular localization | Transporter trafficking |
Transport Assays
Radiolabeled or fluorescent carnitine uptake assays are used to measure carnitine transmembrane transporter activity in cells expressing wild-type or mutant transporters.
CRISPR Knockout and Knock-in Models
CRISPR-Cas9 knockout of SLC22A5 or SLC6A14, and knock-in of specific point mutations, allow functional dissection of carnitine transport in disease models.
Glycosylation Analysis
Mass spectrometry and site-directed mutagenesis can assess glycosylation status of OCTN2 and its impact on transport activity.
Gene Expression Profiling
RNA-seq and qPCR are used to measure expression of carnitine transporters under different conditions, such as PPARγ activation.
How CRISPR Can Be Used to Study GO:0015226 carnitine transmembrane transporter activity
Knockout
CRISPR knockout of SLC22A5 or SLC6A14 eliminates carnitine transport activity, enabling studies of metabolic consequences and disease phenotypes.
Point Mutation
Point mutations can be introduced into carnitine transporter genes to mimic human mutations, such as those causing primary carnitine deficiency, and to study substrate specificity.
Knock-in
Knock-in of tagged or reporter versions of carnitine transporters allows visualization and tracking of transporter localization and dynamics.
Overexpression
Overexpression of SLC6A14 or SLC22A5 in cell lines enhances carnitine uptake, useful for studying cancer-associated fibroblast signaling and metabolic reprogramming.
How EDITGENE Supports carnitine transmembrane transporter activity Research
Researchers studying carnitine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in carnitine transport, metabolic regulation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for carnitine transmembrane transporter activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC22A5 Knockout HEK293 Cell Line | EDJ-KQ2411 | Human | 6584 | Details Get a Quote |
| SLC22A4 Knockout HEK293 Cell Line | EDJ-KQ5800 | Human | 6583 | Details Get a Quote |
| SLC16A9 Knockout HEK293 Cell Line | EDJ-KQ8785 | Human | 220963 | Details Get a Quote |
| SLC22A16 Knockout HEK293 Cell Line | EDJ-KQ9593 | Human | 85413 | Details Get a Quote |
| SLC22A4 Knockout A-549 Cell Line | EDJ-KQ29212 | Human | 6583 | Details Get a Quote |
| SLC22A4 Knockout HCT 116 Cell Line | EDJ-KQ29213 | Human | 6583 | Details Get a Quote |
| SLC22A4 Knockout HeLa Cell Line | EDJ-KQ29214 | Human | 6583 | Details Get a Quote |
| SLC16A9 Knockout HCT 116 Cell Line | EDJ-KQ35061 | Human | 220963 | Details Get a Quote |
| SLC22A5 Knockout HCT 116 Cell Line | EDJ-KQ21586 | Human | 6584 | Details Get a Quote |
| SLC22A5 Knockout A-549 Cell Line | EDJ-KQ22910 | Human | 6584 | Details Get a Quote |
| SLC22A5 Knockout HeLa Cell Line | EDJ-KQ22912 | Human | 6584 | Details Get a Quote |
| SLC22A16 Knockout HeLa Cell Line | EDJ-KQ57710 | Human | 85413 | Details Get a Quote |
| SLC16A9 Knockout HeLa Cell Line | EDJ-KQ59146 | Human | 220963 | Details Get a Quote |
| SLC22A16 Knockout A-549 Cell Line | EDJ-KQ66212 | Human | 85413 | Details Get a Quote |
| SLC16A9 Knockout A-549 Cell Line | EDJ-KQ67620 | Human | 220963 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records
Frequently Asked Questions About carnitine transmembrane transporter activity
What is carnitine transmembrane transporter activity?
It is a molecular function (GO:0015226) that enables the transfer of carnitine across a membrane, supporting acyl group transfer across the inner mitochondrial membrane.
What genes are involved in carnitine transmembrane transporter activity?
Key genes include SLC22A5 (OCTN2), SLC6A14, SLC22A4, and mitochondrial carriers such as SLC25A20.
What diseases are associated with carnitine transport defects?
Primary carnitine deficiency, pancreatic cancer recurrence, and metabolic disorders.
How is carnitine transmembrane transporter activity regulated?
It is regulated by PPARγ signaling, glycosylation, and p53-mediated oxidative stress responses.
What is the synonym for GO:0015226?
The synonym is vitamin Bt transporter activity.
Which transporter is most studied for carnitine uptake?
SLC22A5 (OCTN2) is the most studied high-affinity carnitine transporter.
How can I study carnitine transport in the lab?
Using radiolabeled carnitine uptake assays, CRISPR knockout, point mutation knock-in, and overexpression models.
What is the role of SLC6A14 in cancer?
SLC6A14 mediates carnitine uptake from cancer-associated fibroblasts, promoting pancreatic cancer recurrence.
Does glycosylation affect carnitine transporters?
Yes, glycosylation of OCTN2 affects its transport activity and stability.
What CRISPR models are available for carnitine transporter research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like SLC22A5 and SLC6A14.
Conclusion
Carnitine transmembrane transporter activity (GO:0015226) is a fundamental molecular function required for carnitine uptake and mitochondrial fatty acid oxidation. Its dysregulation is linked to primary carnitine deficiency and cancer progression, making it a critical target for metabolic and oncological research. Advances in CRISPR-based models and transport assays continue to elucidate the mechanisms and therapeutic potential of carnitine transporters.
References
- 1. Zhang J et al.. 2026. SLC6A14-mediated carnitine transmembrane uptake from PPARγ(+) cancer-associated fibroblasts promotes recurrence of pancreatic cancer.. Gut PMID: 41802751
- 2. Palmieri F. 1994. Mitochondrial carrier proteins.. FEBS Lett 346(1):48-54 PMID: 8206158
- 3. Adeva-Andany MM et al.. 2017. Significance of l-carnitine for human health.. IUBMB Life 69(8):578-594 PMID: 28653367
- 4. Raulin J. 2000. Lipids and retroviruses.. Lipids 35(2):123-30 PMID: 10757541
- 5. Bacher P et al.. 2009. Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids.. Biochim Biophys Acta 1788(12):2594-602 PMID: 19814996
- 6. Filippo CA et al.. 2011. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.. Biochim Biophys Acta 1812(3):312-20 PMID: 21126579
- 7. Beyfuss K et al.. 2018. A systematic review of p53 regulation of oxidative stress in skeletal muscle.. Redox Rep 23(1):100-117 PMID: 29298131
- 8. Csala M et al.. 2007. Transport and transporters in the endoplasmic reticulum.. Biochim Biophys Acta 1768(6):1325-41 PMID: 17466261
